Phenobarbital versus benzodiazepines in alcohol withdrawal syndrome
Abstract Aim Phenobarbital, a long‐acting barbiturate, presents an alternative to conventional benzodiazepine treatment for alcohol withdrawal syndrome (AWS). Currently, existing research offers only modest guidance on the safety and effectiveness of phenobarbital in managing AWS in hospital setting...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wiley
2023-12-01
|
| シリーズ: | Neuropsychopharmacology Reports |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1002/npr2.12347 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|